P
Protalix Biotherapeutics Inc
AMEX:PLX
Protalix Biotherapeutics Inc
AMEX:PLX
Price:
2.69
USD
-0.37%
Market Closed
Market Cap:
$216.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
US |
|
Nongfu Spring Co Ltd
OTC:NNFSF
|
CN |
|
R
|
Rio Tinto PLC
XMUN:RIO1
|
UK |
|
Sotera Health Co
NASDAQ:SHC
|
US |
|
China Securities Co Ltd
SSE:601066
|
CN |
|
C
|
Cadiz Inc
F:2ZC
|
US |
|
Universal Health Services Inc
NYSE:UHS
|
US |
|
I
|
Infineon Technologies AG
XHAM:IFX
|
DE |
|
Aptitude Software Group PLC
LSE:APTD
|
UK |
|
D
|
DaVita Inc
SWB:TRL
|
US |
|
T
|
Telefonaktiebolaget LM Ericsson
DUS:ERCB
|
SE |
|
C
|
Crocs Inc
XMUN:C7N
|
US |
|
I
|
IPD Group Ltd
ASX:IPG
|
AU |
|
A
|
ASML Holding NV
DUS:ASME
|
NL |
Multiples-Based Value
The Multiples-Based Value for Protalix Biotherapeutics Inc (PLX) under the Base Case is hidden USD. Compared with the current market price of 2.69 USD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PLX Multiples-Based Value
LOCKED